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January 2012266 VogelSome unexpected STD ratio findings are presented in
Table II. First, STD ratios for symptomatic patients in the
NIS are substantially lower than for asymptomatic NIS
patients even though symptomatic patients ordinarily have
more periprocedural strokes. Second, STD ratios for symp-
tomatic NIS patients also are low in comparison to symp-
tomatic patients in randomized trials, especially among
those who had CAS. In this subset, the STD ratios in NIS
studies ranged only from 0.6:1 to 1.1:1, compared to a
range of 3.3:1 to 11:1 in the trials. There is no obvious
clinical explanation for this, so it may be related to errors in
documentation and/or coding. Either too few strokes or
toomany deaths seem to be present in certain subsets of the
NIS data. It would be practically impossible for a hospital
coder to mistakenly enter a death while preparing a dis-
charge abstract, so strokes are more logical sources of error.
CONCLUSION
In addition to the absence of 30-day event rates, the
author must conclude that preprocedural symptoms and
periprocedural strokes are under-reported in the NIS on
the basis of coding errors and/or a lack of clarity with which
these events are documented in medical records. The only
alternatives are to believe that as few as 3% of patients are
symptomatic before CEA or CAS, and that the stroke risks
of these procedures are collectively lower at a thousand
community hospitals in the NIS than they are in CREST.
Neither of these alternatives seems plausible.
The author gratefully acknowledges Jacqueline Mat-
thews, RN, MS, Director of External Quality Reporting at
the Cleveland Clinic, for reviewing the manuscript regard-
ing the process of ICD-9-CM coding in hospital discharge
abstracts.
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Dr Hertzer has presented an insightful article demonstrating
the shortcomings of administrative data research and the variation
ndings, is a well-documented phenomenon in all administrative
ata studies.1,2 TheNIS is well suited for “hard” end points such as
ortality rates, procedures, and discharge disposition, but the
oding of comorbidities and complications is often variable.
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Volume 55, Number 1 Vogel 267Administrative discharge data was originally designed for bill-
ing purposes, and subsequently, clinical information is limited by
the code schemes of the International Classification of Diseases,
9th Clinical Modification. Definitions of coding can vary be-
tween institutions and hospital coders. Therefore, more subtle
diagnoses, such as transient cerebral ischemia or amaurosis
fugax, are often not appropriately captured in administrative
data and lead to the low rates of symptomatic patients reported
in all NIS studies. Other limitations of the NIS data include the
lack of longitudinality, which does not allow for analysis of
readmission rates and complications after hospital discharge. As
well, administrative databases often lack information regarding
diagnoses “present on admission” and present difficulty discern-
ing between hospital-acquired complications and conditions
patients had before admission.
However, administrative data do allow for the analysis of large
numbers of procedures and can reflect population-level trends and
outcomes. Although randomized controlled trials evaluate pre-
defined situations, administrative studies assess outcomes of inter-
ventions across all practitioners and institutions. Furthermore,
administrative studies can be performed with substantially less time
and cost, providing hypothesis-generating findings. Validation of
specific codes and diagnoses contained within the NIS would be
extremely useful but has not occurred due to cost and technical
feasibility.
Despite these limitations, the NIS data set can certainly be
used to critically evaluate carotid interventions. Examination of
stroke rates using expanded coding parameters in conjunction withtrict exclusion criteria to ensure only elective cases are captured
ields stroke rates in theNIS that are quite comparable (4.16% after
arotid artery stenting and 2.66% after carotid endarterectomy)
ith the Carotid Revascularization Endarterectomy vs Stent Trial
rial (4.1% after carotid artery stenting and 2.3% after carotid
ndarterectomy).3 Therefore, code selection and study design,
ccounting for the inherent limitations of the NIS, can yield
omparable results.
In the future, coding inconsistencies will become more
ignificant to practitioners as readmission measures designed to
eflect “the quality of care” are created using these same codes.
his should reinforce the importance of physician involvement
n outcome studies and analysis. In conclusion, NIS studies have
onsistently reported the global superiority of carotid endarter-
ctomy in the United States population but certainly fall short in
roviding the refined clinical data provided from randomized
ontrolled trials and clinical series.
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